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Summary
Examination of ciliary ultrastructure remains the cornerstone diagnostic test for primary ciliary 
dyskinesia (PCD), a disease of abnormal ciliary structure and/or function. Obtaining a biopsy with 
sufficient interpretable cilia and producing quality transmission electron micrographs (TEM) is 
challenging. Methods for processing tissues for optimal preservation of axonemal structures are 
not standardized. This study describes our experience using a standard operating procedure (SOP) 
for collecting nasal scrape biopsies and processing TEMs in a centralized laboratory. We enrolled 
patients with suspected PCD at research sites of the Genetic Disorders of Mucociliary Clearance 
Consortium. Biopsies were performed according to a SOP whereby curettes were used to scrape 
the inferior surface of the inferior turbinate, with samples placed in fixative. Specimens were 
shipped to a central laboratory where TEMs were prepared and blindly reviewed. 448 specimens 
were obtained from 107 young children (0–5 years), 189 older children (5–18 years), and 152 
adults (> 18 years), and 88% were adequate for formal interpretation. The proportion of adequate 
specimens was higher in adults than in children. 50% of the adequate TEMs showed normal 
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ciliary ultrastructure, 39% showed hallmark ultrastructural changes of PCD, and 11% had 
indeterminate findings. Among specimens without clearly normal ultrastructure, 72% had defects 
of the outer and/or inner dynein arms, while 7% had central apparatus defects with or without 
inner dynein arm defects. In summary, nasal scrape biopsies can be performed in the outpatient 
setting and yield interpretable samples, when performed by individuals with adequate training and 
experience according to an SOP.
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Introduction
Primary ciliary dyskinesia (PCD) is a rare genetic disease characterized by abnormal ciliary 
structure and/or function1. The diagnosis of PCD is based on the presence of a typical 
clinical phenotype combined with identification of ciliary dysmotility and/or specific ciliary 
ultrastructural defects2,3. Even though genetic testing is useful in a subset of PCD patients 
(~20–25%), examination of ciliary ultrastructure remains the cornerstone diagnostic test for 
PCD. Yet, it is challenging to obtain an adequate biopsy specimen with a sufficient number 
of cilia that are technically satisfactory for accurate interpretation. Some clinical reference 
laboratories report that up to 80% of cilia samples submitted are unsatisfactory and 
inadequate for evaluation4. Further, significant expertise is required to produce high quality 
transmission electron micrographs (TEM) which are adequate to discriminate primary 
(“genetic”) versus secondary (“non-specific”) defects in ciliary ultrastructure. As a result, 
the diagnosis is often delayed or uncertain. Since the specialized techniques and expertise 
required for PCD diagnosis are not standardized or readily available, it has been suggested 
that patients suspected of having PCD be referred to tertiary diagnostic centers5.
Respiratory ciliated cells can be obtained either by nasal or tracheal brushings or biopsies. 
Most previous studies have described the frequency of detecting different ultrastructural 
abnormalities using these different techniques and the ability to distinguish between primary 
and secondary ultrastructural defects6–9. Only a few have examined the diagnostic yields 
and success rates of different techniques6,10. Papon and colleagues reported that TEM was 
more feasible in adults than in children, regardless of the biopsy site, at a large referral 
center in France10.
The objective of this study was to describe the North American multicenter experience of 
the Genetic Disorders of Mucociliary Clearance Consortium, a member of the Rare Disease 
Clinical Research Network. This consortium uses a standardized operating procedure (SOP) 
for the collection, fixation, TEM preparation, and centralized interpretation of nasal scrape 
biopsy specimens for the diagnosis of PCD.
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Subjects with suspected PCD were recruited for the study from around North America 
through contact with referring physicians, the PCD Foundation (www.pcdfoundation.org) 
and a national website (http://rarediseasesnetwork.epi.usf.edu/gdmcc/index.htm). These 
subjects were studied at one of seven clinical research sites of the Genetic Disorders of 
Mucociliary Clearance Consortium (see Appendix 1). At their study visits, all subjects 
underwent comprehensive clinical and laboratory evaluations. Other pathologic conditions 
such as cystic fibrosis, asthma, allergies, and immunodeficiency were excluded previously 
or at their study visits. Institutional Review Boards approved the protocols at each of the 
research sites. Informed consent was obtained from each of the subjects and/or their parents.
Ciliary Biopsy and Ultrastructure Evaluation
Prior to starting the study, a training session on biopsy and fixation techniques was held for 
investigators from each research site. This training session included a powerpoint 
presentation and face-to-face instruction from a single trainer (J. Carson) as well as 
individual demonstrations of nasal curettage on physician volunteers and immediate 
feedback on sample quality using light microscopy. Nasal scrape biopsies were performed 
using a curettage technique according to a SOP (see Appendix 2) whereby ciliated epithelial 
cells were obtained from the inferior surface of the inferior nasal turbinate. The curettes 
(Rhino-Pro®, Arlington Scientific, Inc) were immediately immersed in a cold fixative 
consisting of 2% glutaraldehyde, 2% paraformaldehyde, and 0.5% tannic acid11. This 
fixative was prepared by thawing and mixing a vial of frozen glutaraldehyde and 
paraformaldehyde with a vial of frozen tannic acid just prior to the specimen collection. 
Tissue specimens were stored refrigerated and shipped to a centralized laboratory at the 
University of North Carolina Chapel Hill.
TEMs were prepared by one individual (KB) and reviewed in a blinded fashion by 3 
independent observers using previously described techniques12,13. Adequacy of the samples 
was based on the presence of an adequate number of ciliated cells that were technically 
sufficient for interpretation, and most samples had ≥ 20 cross sections of cilia. Nasal scrape 
specimens were typically deemed inadequate for formal evaluation if too few or no ciliated 
cells were identified in the sample, or occasionally, if low quality TEM images were 
produced, generally due to poor preservation of the sample. Reviewers examined the TEMs 
for absence or shortening of outer and inner dynein arms and for gross abnormalities in the 
central apparatus (central pairs, radial spokes). Subjects were classified as having either 
normal ciliary structure, absent or shortened outer dynein arms (ODA) alone, absent or 
shortened inner dynein arms (IDA) alone, combined defects of both the outer and inner 
dynein arms, central apparatus abnormalities including transpositions, combined defects of 
the IDA and central apparatus, or indeterminate findings. Samples were reported as 
indeterminate when abnormalities were not sufficiently clear to indicate a “hallmark” PCD 
ciliary defect, as these were most likely secondary abnormalities (e.g. compound cilia, 
ciliary disorientation, ciliary changes in cells exhibiting cytopathic effects).
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Data were analyzed using PASW Statistics v18 (SPSS Inc., Chicago, IL, USA). We used 
Chi-squared analyses and Fisher’s exact test when examining differences between sites and 
age groups. The forced expiratory volume in 1 second (FEV1) was expressed as percent of 
predicted normal using reference equations.14 Differences were considered statistically 
significant at p<0.05.
Results
The demographic and clinical characteristics of the referral subjects are listed in Table 1. 
Using the SOP, the 7 sites had an overall 88% success rate (394/448 samples) in acquiring 
specimens adequate for formal interpretation (Figure 1). Among TEMs adequate for formal 
evaluation (n=394), 50% (196/394) demonstrated normal ciliary ultrastructure, 39% 
(155/394) had hallmark ultrastructural changes of PCD, and 11% (43/394) had 
indeterminate findings. The success rates in acquiring adequate specimens varied among 
sites (Figure 2), with site 1 acquiring a significantly greater proportion of adequate samples 
than the other sites (92%, p<0.03) and sites 2 and 6 acquiring significantly fewer adequate 
samples (73%, p<0.001 and 69%, p<0.004, respectively). Site 7 had a failure rate 
comparable to sites 2 and 6 (30%), but due to the low number of samples performed, this 
result did not reach statistical significance (p=0.058). Site 1 performed the most procedures 
(n= 223) and sites 6 and 7 the least (29 and 13, respectively). At site 2, there was 
improvement over time, evidenced by the fact that among the first 18 specimens, only 8 
(44%) were adequate for formal evaluation, whereas among the final 37 specimens, 32 
(86%) were adequate. There was site to site variability in the proportion of abnormal 
specimens among the specimens from which a diagnosis could be made (Figure 2). Sites 2 
and 4 had a significantly higher proportion of abnormal specimens (71%, p<0.01 and 75%, 
p<0.02 respectively) and site 3 had a significantly lower proportion of abnormal specimens 
(6.8%, p<0.001) in comparison to the other sites.
Subject age factored into the likelihood of success. The success rate in acquiring specimens 
adequate for formal evaluation was higher in adults (93%) than in subjects under 18 years 
(86%, p<0.02, Figure 3). The success rate was similar between specimens from children 
under 5 years of age (85%) versus specimens from children aged 5 to 18 years (86%). The 
age distribution at sites with lower success rates was similar to the distribution at other study 
sites.
The distribution of TEM-based diagnoses among the interpretable nasal scrape biopsies is 
shown in Figure 4. Among specimens without clearly normal ultrastructural findings 
(198/394), 42% displayed ODA defects, 12% showed IDA defects, and 18% showed 
combined ODA and IDA defects. Isolated central apparatus defects were rare (0.5%), but 
6% of specimens showed combined central apparatus and IDA defects. No definitive 
diagnosis could be made from the remainder of the abnormal “indeterminate” specimens.
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In this multicenter study, we report a high success rate in obtaining nasal scrape biopsy 
specimens adequate for formal interpretation of ciliary ultrastructure. Experience appeared 
to be a factor in success rates, as the sites performing the highest volume of biopsies had the 
highest proportion of adequate specimens and the two sites performing the lowest volume 
had the lowest proportions of adequate specimens. Though differences were modest, nasal 
scrape biopsies were more successful in adults than in children. In this cohort of subjects 
with suspected or possible PCD, half had normal ciliary ultrastructure. Among those with 
ultrastructural abnormalities consistent with PCD, 72% involved a truncation or absence of 
outer and/or inner dynein arms while 7% involved central apparatus defects in isolation or in 
combination with IDA defects.
This is one of the largest reported series of biopsies to evaluate ciliary ultrastructure. When 
compared with other large studies, we achieved a high success rate in obtaining specimens 
adequate for formal evaluation 7,10,15. Two of the prior series were performed at a single 
center and the third series did not standardize the collection procedures among contributing 
sites. In the series reported by Papon and colleagues10, almost two thirds of pediatric 
specimens were bronchial biopsies in contrast to our study in which all specimens were 
obtained from nasal epithelium. The Papon group found that age was more of a factor than 
biopsy location (upper versus lower airway) in determining specimen adequacy, with lower 
rates of adequacy among children from both nasal scrapes and tracheal biopsies when 
compared to adults. While we similarly found a higher success rate in adults in comparison 
to children, the differences were modest and we still had an approximate 85% success rate in 
children.
We attribute our high rate of specimens adequate for formal interpretation to the 
establishment of strict procedural guidelines and a training session before starting the study. 
Care was taken to standardize the biopsy, fixation, and transport of specimens. The vast 
majority of these samples were collected without anesthesia in outpatient clinics. All 
samples were interpreted at a single site, by consensus opinion of three blinded observers, 
minimizing differential error at the interpretation step. Despite the standardization of 
procedures, experience still played a role in the success rates as the sites performing the 
highest volume of biopsies had the highest proportion of interpretable specimens. The most 
common reason for an inadequate specimen was a sample with too few or no ciliated cells 
identified. Direct feedback to centers with higher proportions of inadequate samples 
improved subsequent sample quality. The French experience highlights the fact that a large 
portion of nasal specimens inadequate for formal evaluation lack sufficient numbers of cilia, 
either due to the low density of cilia, the lack of epithelial tissue acquired, or squamous 
metaplasia10.
Our experience has implications for clinical practice involving PCD testing. First, we 
showed that it is possible to obtain nasal scrape biopsies adequate for formal interpretation 
in outpatient clinics, saving time and money, and avoiding the sedation risk associated with 
bronchial biopsies. We also showed that even among our specialized centers, additional 
training may be needed to improve the success rate at low volume sites. It is important to 
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note that a normal TEM, in the absence of ciliary function studies, does not exclude PCD as 
a diagnostic consideration as evidenced most strongly by disease-causing mutations in the 
DNAH11 gene16–18. Despite 50% of our cohort having normal ciliary ultrastructure, some 
of these individuals have a classic clinical phenotype and low nasal nitric oxide levels, and 
may in fact have disease causing mutations in DNAH11 or in genes yet to be 
determined2,3,18.
This study has some limitations. While describing differences in success rates based on site 
or subject age, we note that the study was not designed or powered to evaluate specific 
predictors of success, but rather to describe our experience. The study was also not designed 
to demonstrate the highest yield biopsy location in the airway. We used the inferior surface 
of the inferior nasal turbinate for its ease of access in the outpatient setting coupled with its 
high percentage of ciliated epithelial cells19. Additionally, by using three investigators at a 
single site to evaluate all specimens, we may have introduced observer bias in interpretation 
of specimens although the blinded review should have minimized these biases. While the 
use of a single site to interpret specimens was appropriate for methodologic reasons in this 
clinical research study, this is not feasible for patients being seen clinically throughout the 
country. This study may also have some ascertainment bias in that approximately one half of 
the samples came from a single site. Further, this study did not compare the effects of 
different fixatives on TEM quality. Therefore, we cannot comment on whether the 
combination of glutaraldehyde, paraformaldehyde and tannic acid is any better than standard 
glutaraldehyde fixative. And finally, our consortium did not universally perform ciliary 
motion analysis as part of our diagnostic approach, 20 precluding us from determining how 
assessment of ciliary function aids in the diagnosis of PCD.
Despite these limitations, by using a standardized approach for procuring and processing 
nasal epithelium, we were able to offer a precise TEM-based diagnosis in the majority of 
subjects with abnormal electron microscopy. Until more comprehensive genetic testing 
becomes available, TEM currently is and will remain the cornerstone diagnostic test for 
PCD for at least the next few years. In summary, nasal scrape biopsies can be performed in 
the outpatient setting and generally yield interpretable samples, when performed by 
individuals with adequate training and experience according to an SOP.
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Distribution of ciliary biopsy results from all sites. 88% of all biopsies were adequate for 
formal interpretation.
Olin et al. Page 9























Distribution of ciliary biopsy results by site. All sites had 69% of samples that were 
adequate for formal interpretation.
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Percentage of nasal scrape biopsies by age that was adequate for formal interpretation. 85% 
of biopsies in infants and toddlers were adequate, but there was a higher success rate in 
those over 18 versus those under 18 (p <0.02).
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Distribution of TEM diagnoses among interpretable nasal scrape biopsies. ODA defects 
were the most common abnormality. Note the low frequency of central apparatus defects.
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